Discover Exelixis’ Q3 2025 earnings highlights—rising cabozantinib demand, strategic growth, and focused capital management.

THOUSAND OAKS, Calif., Nov. 4, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced financial results for the third quarter of 2025.

For more than 30 years, thanks to bipartisan congressional support, the 340B program has helped eligible hospitals stretch limited federal resources to reduce the price of outpatient pharmaceuticals ...

Oklahoma stepped in to save hospital profits with a new law, but a federal judge put it on hold while drugmakers argue its ...

Inside Providence plan 340B rebate disruption details the system’s financial and operational readiness for the new federal rebate pilot program.

Court rejects AbbVie 340B restrictions, upholding Colorado law protecting contract pharmacies under the 340B Drug Pricing Program.

Nonprofit hospitals and health clinics are alarmed about a change that's coming to federal drug purchasing discounts next ...

A policy of giving out regular, unconditional cash payments is gaining popularity as the cost of living grows and AI looms ...

Oklahoma Attorney General Gentner Drummond is vowing to fight back against a federal injunction limiting enforcement of House Bill 2048.

From rising premiums to fewer plan choices, this guide walks you through reviewing benefits, checking provider networks and ...